{"filing":{"accession_number":"0001493152-26-028686","cik":"0001006028","ticker":"PURE","company_name":"PURE BIOSCIENCE, INC.","form":"8-K","filing_date":"2026-06-15","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315226028686/form8-k.htm"},"events":[{"id":11012,"run_id":9651,"accession_number":"0001493152-26-028686","anchor_item_number":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Item 2.02 discloses that on June 15, 2026, PURE Bioscience issued a press release announcing financial results for the fiscal third quarter ended April 30, 2026. The press release is attached as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02 of Form 8-K.","company_name":"PURE BIOSCIENCE, INC.","ticker":"PURE","filing_date":"2026-06-15","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":7485,"accession_number":"0001493152-26-028686","item_number":null,"item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Item 2.02 discloses that on June 15, 2026, PURE Bioscience issued a press release announcing financial results for the fiscal third quarter ended April 30, 2026. The press release is attached as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02 of Form 8-K.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-15T20:08:35.558820+00:00","company_name":"PURE BIOSCIENCE, INC.","ticker":"PURE","filing_date":"2026-06-15"}]}